ArticleDepression and anxiety2026
Disrupted Global Brain Dynamics in Adolescents With Comorbid Anxiety and Depression: Neural Mechanisms and Classification Based on EEG Microstates.
Article in Depression and anxiety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adolescents with comorbid anxiety and depression (ACAD) represent a significant mental health challenge that necessitates the identification of objective neurobiological markers for accurate diagnosis and intervention. Previous electroencephalography (EEG) studies have often relied on single-domain or single-feature analyses, which may fail to capture the multidimensional nature of the underlying neuropathology. This study aimed to characterize neurophysiological alterations in adolescents with ACAD using a multidimensional EEG analytical framework integrating spectral power, functional connectivity (FC), and microstate (MS) dynamics. Methods: Forty adolescents with ACAD and 42 healthy controls (HCs) were included. Resting-state EEG data were analyzed to extract spectral power, weighted phase lag index-based FC, and MS parameters. Three types of support vector machine (SVM) classification were implemented, including single-feature SVM analysis, multivariate SVM (MV-SVM) without principal component (PC) analysis (PCA), and PCA-based SVM, to distinguish the independent discriminative value of individual features from the effects of multivariate feature integration and PCA-based dimensionality reduction. Results: Adolescents with ACAD showed marginally reduced delta power, altered alpha-band FC, and disrupted MS dynamics, including altered MS class expression and abnormal transition probabilities. Among individual MS features, the transition probability from MS B to MS C showed the highest independent discriminative value, achieving an accuracy of 75% and an area under the receiver operating characteristic (ROC) curve (AUC) of 0.86. Multivariate integration of all MS parameters substantially improved classification performance, with the MV-SVM achieving an accuracy of 0.95 and an AUC of 0.98. The PCA -SVM model showed comparable performance, with an accuracy of 0.94 and an AUC of 0.98, while reducing correlated MS features to three PCs explaining more than 90% of the variance. Conclusion: These findings suggest that adolescent ACAD is characterized by global dynamic network dysregulation rather than isolated local abnormalities. Integrated MS dynamics, particularly when modeled in a multivariate framework, may serve as candidate biomarkers for distinguishing adolescents with ACAD from HCs. This multidimensional EEG approach may contribute to early detection, risk stratification, and targeted intervention in adolescent mental health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.